Cargando…
Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain
BACKGROUND: MCP-1 is known to be an important chemokine for macrophage recruitment. Thus, targeting MCP-1 may prevent the perturbations associated with macrophage-induced inflammation in adipose tissue. However, inconsistencies in the available animal literature have questioned the role of this chem...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854829/ https://www.ncbi.nlm.nih.gov/pubmed/26620890 http://dx.doi.org/10.1038/ijo.2015.244 |
_version_ | 1782430255984672768 |
---|---|
author | Cranford, Taryn L. Enos, Reilly T. Velázquez, Kandy T. McClellan, Jamie L. Davis, J. Mark Singh, Udai P. Nagarkatti, Mitzi Nagarkatti, Prakash S. Robinson, Cory M. Murphy, E. Angela |
author_facet | Cranford, Taryn L. Enos, Reilly T. Velázquez, Kandy T. McClellan, Jamie L. Davis, J. Mark Singh, Udai P. Nagarkatti, Mitzi Nagarkatti, Prakash S. Robinson, Cory M. Murphy, E. Angela |
author_sort | Cranford, Taryn L. |
collection | PubMed |
description | BACKGROUND: MCP-1 is known to be an important chemokine for macrophage recruitment. Thus, targeting MCP-1 may prevent the perturbations associated with macrophage-induced inflammation in adipose tissue. However, inconsistencies in the available animal literature have questioned the role of this chemokine in this process. The purpose of this study was to examine the role of MCP-1 on obesity-related pathologies. METHODS: Wild-type (WT) and MCP-1 deficient mice on an FVB/N background were assigned to either low-fat-diet (LFD) or high-fat-diet (HFD) treatment for a period of 16 weeks. Body weight and body composition were measured weekly and monthly, respectively. Fasting blood glucose and insulin, and glucose tolerance were measured at 16 weeks. Macrophages, T cell markers, inflammatory mediators, and markers of fibrosis were examined in the adipose tissue at sacrifice. RESULTS: As expected, HFD increased adiposity (body weight, fat mass, fat percent, and adipocyte size), metabolic dysfunction (impaired glucose metabolism and insulin resistance) macrophage number (CD11b(+)F480(+) cells, and gene expression of EMR1 and CD11c), T cell markers (gene expression of CD4 and CD8), inflammatory mediators (pNFκB and pJNK, and mRNA expression of MCP-1, CCL5, CXCL14, TNF-α, and IL-6), and fibrosis (expression of IL-10, IL-13, TGF-β, and MMP2) (P<0.05). However, contrary to our hypothesis, MCP-1 deficiency exacerbated many of these responses resulting in a further increase in adiposity (body weight, fat mass, fat percent and adipocyte size), metabolic dysregulation, macrophage markers (EMR1), inflammatory cell infiltration, and fibrosis (formation of type I and III collagens, mRNA expression of IL-10 and MMP2) (P<0.05). CONCLUSIONS: These data suggest that MCP-1 may be a necessary component of the inflammatory response required for adipose tissue protection, remodeling, and healthy expansion in the FVB/N strain in response to HFD feedings. |
format | Online Article Text |
id | pubmed-4854829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-48548292016-06-01 Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain Cranford, Taryn L. Enos, Reilly T. Velázquez, Kandy T. McClellan, Jamie L. Davis, J. Mark Singh, Udai P. Nagarkatti, Mitzi Nagarkatti, Prakash S. Robinson, Cory M. Murphy, E. Angela Int J Obes (Lond) Article BACKGROUND: MCP-1 is known to be an important chemokine for macrophage recruitment. Thus, targeting MCP-1 may prevent the perturbations associated with macrophage-induced inflammation in adipose tissue. However, inconsistencies in the available animal literature have questioned the role of this chemokine in this process. The purpose of this study was to examine the role of MCP-1 on obesity-related pathologies. METHODS: Wild-type (WT) and MCP-1 deficient mice on an FVB/N background were assigned to either low-fat-diet (LFD) or high-fat-diet (HFD) treatment for a period of 16 weeks. Body weight and body composition were measured weekly and monthly, respectively. Fasting blood glucose and insulin, and glucose tolerance were measured at 16 weeks. Macrophages, T cell markers, inflammatory mediators, and markers of fibrosis were examined in the adipose tissue at sacrifice. RESULTS: As expected, HFD increased adiposity (body weight, fat mass, fat percent, and adipocyte size), metabolic dysfunction (impaired glucose metabolism and insulin resistance) macrophage number (CD11b(+)F480(+) cells, and gene expression of EMR1 and CD11c), T cell markers (gene expression of CD4 and CD8), inflammatory mediators (pNFκB and pJNK, and mRNA expression of MCP-1, CCL5, CXCL14, TNF-α, and IL-6), and fibrosis (expression of IL-10, IL-13, TGF-β, and MMP2) (P<0.05). However, contrary to our hypothesis, MCP-1 deficiency exacerbated many of these responses resulting in a further increase in adiposity (body weight, fat mass, fat percent and adipocyte size), metabolic dysregulation, macrophage markers (EMR1), inflammatory cell infiltration, and fibrosis (formation of type I and III collagens, mRNA expression of IL-10 and MMP2) (P<0.05). CONCLUSIONS: These data suggest that MCP-1 may be a necessary component of the inflammatory response required for adipose tissue protection, remodeling, and healthy expansion in the FVB/N strain in response to HFD feedings. 2015-12-01 2016-05 /pmc/articles/PMC4854829/ /pubmed/26620890 http://dx.doi.org/10.1038/ijo.2015.244 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Cranford, Taryn L. Enos, Reilly T. Velázquez, Kandy T. McClellan, Jamie L. Davis, J. Mark Singh, Udai P. Nagarkatti, Mitzi Nagarkatti, Prakash S. Robinson, Cory M. Murphy, E. Angela Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title | Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title_full | Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title_fullStr | Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title_full_unstemmed | Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title_short | Role of MCP-1 on Inflammatory Processes and Metabolic Dysfunction Following High-Fat Feedings in the FVB/N Strain |
title_sort | role of mcp-1 on inflammatory processes and metabolic dysfunction following high-fat feedings in the fvb/n strain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854829/ https://www.ncbi.nlm.nih.gov/pubmed/26620890 http://dx.doi.org/10.1038/ijo.2015.244 |
work_keys_str_mv | AT cranfordtarynl roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT enosreillyt roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT velazquezkandyt roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT mcclellanjamiel roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT davisjmark roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT singhudaip roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT nagarkattimitzi roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT nagarkattiprakashs roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT robinsoncorym roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain AT murphyeangela roleofmcp1oninflammatoryprocessesandmetabolicdysfunctionfollowinghighfatfeedingsinthefvbnstrain |